Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study of risk of lymphoid malignancy associated with cancer predisposition genes finds ATM, CHEK2, and TP53 mutations, among others, predispose to myeloma.”
“Risk of lymphoid malignancy associated with cancer predisposition genes”
Authors: Nicholas Boddicker, Raphael Mwangi, Dennis Robinson, Cristine Allmer, Allison Rosenthal, Thomas Witzig, Anne Novak, Susan Slager, Celine Vachon, James Cerhan et al.
More posts featuring Robert Orlowski.
